Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
56
ALLO Quote, Financials, Valuation and Earnings
Last price:
$1.40
Seasonality move
:
-2.13%
Day range:
$1.38 - $1.52
52-week range:
$0.86 - $3.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2,442.58x
P/B ratio:
0.97x
Volume:
2.4M
Avg. volume:
2.5M
1-year change:
-21.39%
Market cap:
$306.8M
Revenue:
$22K
EPS (TTM):
-$0.98
Earnings Data
Next earnings date for ALLO
Mar 19
2026
Most recent earnings per share
-$0.19
Beat by $0.05
(Nov 6/2025)
Consensus Estimate
-$0.23
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ALLO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/19/2026 | Q4 | $1.8K | -- | -- | -$0.22 | -- |
| 11/06/2025 | Q3 | $1.8K | -- | -$0.19 | -$0.23 | $0.05 |
| 08/13/2025 | Q2 | -- | -- | -$0.23 | -$0.27 | $0.04 |
| 05/15/2025 | Q1 | $1.7K | -- | -$0.28 | -$0.30 | $0.02 |
| 03/13/2025 | Q4 | $12K | -- | -$0.28 | -$0.32 | $0.04 |
| 11/07/2024 | Q3 | $10.7K | -- | -$0.32 | -$0.33 | $0.01 |
| 08/07/2024 | Q2 | $893.9K | -- | -$0.35 | -$0.35 | -$0.00 |
| 05/13/2024 | Q1 | $10.4K | $22K | -$0.38 | -$0.41 | $0.03 |
| 03/14/2024 | Q4 | $22.4K | $21K | -$0.51 | -$0.44 | -$0.07 |
| 11/02/2023 | Q3 | -- | -- | -$0.37 | -$0.52 | $0.15 |
| 08/02/2023 | Q2 | -- | -- | -$0.53 | -$0.59 | $0.06 |
| 05/03/2023 | Q1 | -- | -- | -$0.68 | -$0.62 | -$0.06 |
| 02/28/2023 | Q4 | -- | -- | -$0.66 | -$0.69 | $0.03 |
| 11/02/2022 | Q3 | -- | -- | -$0.58 | -$0.65 | $0.07 |
| 08/09/2022 | Q2 | -- | -- | -$0.52 | -$0.61 | $0.09 |
| 05/04/2022 | Q1 | -- | -- | -$0.56 | -$0.58 | $0.02 |
| 02/23/2022 | Q4 | -- | -- | -$0.54 | -$0.59 | $0.05 |
| 11/04/2021 | Q3 | -- | -- | -$0.57 | -$0.56 | -$0.01 |
| 08/04/2021 | Q2 | -- | -- | -$0.53 | -$0.54 | $0.01 |
| 05/05/2021 | Q1 | -- | -- | -$0.25 | -$0.40 | $0.15 |
| 02/25/2021 | Q4 | -- | -- | -$0.53 | -$0.55 | $0.02 |
| 11/04/2020 | Q3 | -- | -- | -$0.52 | -$0.55 | $0.03 |
| 08/05/2020 | Q2 | -- | -- | -$0.53 | -$0.54 | $0.01 |
| 05/06/2020 | Q1 | -- | -- | -$0.50 | -$0.58 | $0.08 |
| 02/27/2020 | Q4 | -- | -- | -$0.58 | -$0.68 | $0.10 |
| 11/05/2019 | Q3 | -- | -- | -$0.50 | -$0.54 | $0.04 |
| 08/07/2019 | Q2 | -- | -- | -$0.41 | -$0.44 | $0.03 |
| 05/07/2019 | Q1 | -- | -- | -$0.32 | -$0.44 | $0.12 |
| 03/08/2019 | Q4 | -- | -- | -$0.37 | -$0.25 | -$0.12 |
| 11/21/2018 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
Allogene Therapeutics, Inc. Earnings Questions
-
How Much did Allogene Therapeutics, Inc. Generate in Revenue Last Quarter?
Allogene Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Allogene Therapeutics, Inc. Beat Earnings Last Quarter?
Allogene Therapeutics, Inc. announced earnings per share of -$0.19 which represents a beat of analyst forecast a -$0.23 per share.
-
Is Allogene Therapeutics, Inc. Profitable?
Allogene Therapeutics, Inc. reported -$3.1M that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Allogene Therapeutics, Inc. EPS Next Year?
Allogene Therapeutics, Inc.'s earnings are forecast to decrease from -$1.32 per share to -$1.32 per share next year representing a decrease of -29.16%.
-
When is Allogene Therapeutics, Inc.'s Earnings Date?
Allogene Therapeutics, Inc.'s next earnings date is March 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
